GE pours funds into cancer
September 16, 2011
GE Healthcare has upped its
commitment to the eradication of
cancer, with a massive $100 million
challenge to find and fund ideas to
accelerate breast cancer detection
and improve care.
Launched today in collaboration
with several healthcare and
financial partners, the initiative
aims to accelerate cancer
innovation and improve care for
patients over the next nine years by
funding promising ideas to improve
breast cancer diagnostics.
In addition GE has also committed
a further $1 billion to R&D to
expand its suite of technologies for
cancer detection and treatment
over the next five years.
“We envision a day when cancer
is no longer a deadly disease,” said
Jeff Immelt, CEO and Chairman, GE.
“When you add our cutting edge
cancer detection technologies to
the innovative ideas of our new
partners, it’s a powerful formula for
tackling cancer and helping doctors
and researchers improve care”.
GE Australia and NZ ceo Steve
Sargent said a one percent cut in
the cancer cost burden would save
Australia $190 million annually.
“The opportunity to work with
government and the Australian
research and healthcare community
towards such outcomes is both
exciting and humbling,” he said.
See www.healthymagination.com
to learn more about the initiative.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 11
Warning: Undefined variable $flipbook_id in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1259
Warning: Undefined variable $o_shortcode_atts in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1263
Warning: Undefined variable $output in
/home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line
1266
